View Author
mutation leukemia cebpa patient fusion −/− es cells 98/nsd myeloid leukemia expression relapse metabolite myeloid diagnosis protein table sample nup 98/nsd group study compound assay survival biotransformation adult blood deletion -47 aberration potency analysis bcr-abl figure nup 98/nsd cases repair treatment incubation oh-bde fusion proteins cohort response parent probe concentration lymphoblastic leukemia 3/itd 2sult number ikzf 1 deletions damage factor immunobead bioassay apoptosi bde -47 cebpa mutations extract children outcome xpa −/− prognostic value dna damage bde -47 metabolites result antibody relapse samples detection cd 73 lesion parent compound lymphoblastic ttr-binding parent compounds potencie cancer frequency fication level erasmus mc
8 Most Recent Publications
|
NUP98/NSD1 characterizes a novel poor prognostic group in acute myeloid leukemia with a distinct HOX gene expression pattern
(Article)
Hollink, I.H.I.M. Heuvel-Eibrink, M.M. van den Trka, J. Baruchel, A. Zimmermann, M. Creutzig, U. Reinhardt, D. Pieters, R. Valk, P.J.M. Zwaan, C.M. Arentsen-Peters, S.T.C.J.M. Pratcorona, M. Abbas, S. Kuipers, J.E. Galen, J.F. Beverloo, H.B. Sonneveld, E. Kaspers, G.J.J.L. |
2011-09-29
|
|
CD73 (5′-nucleotidase) expression has no prognostic value in children with acute lymphoblastic leukemia
(Article)
Wieten, E. Linden-Schrever, B.E.M. van der Sonneveld, E. Veerman, A.J.P. Pieters, R. |
2011-08-01
|
|
Characterization of CEBPA mutations and promoter hypermethylation in pediatric acute myeloid leukemia
(Article)
Hollink, I.H.I.M. Heuvel-Eibrink, M.M. van den Trka, J. Baruchel, A. Creutzig, U. Pieters, R. Reinhardt, D. Zwaan, C.M. Arentsen-Peters, S.T.C.J.M. Zimmermann, M. Peeters, J. Valk, P.J.M. Balgobind, B.V. Sonneveld, E. Kaspers, G.J. Bont, E.S.J.M. de |
2011-03-01
|
|
TET2 mutations in childhood leukemia
(Article)
Langemeijer, S.M.C. Jansen, J.H. Heuvel-Eibrink, M.M. van den Sonneveld, E. Hoogerbrugge, P.M. Geurts van Kessel, A.H.M. Kuiper, R.P. Hooijer, J. Hoogen , P. Stevens-Linders, E. Massop, M. Waanders, E. Reijmersdal, S.V. van Stevens-Kroef, M. Zwaan, C.M. |
2010-11-02
|
|
Detection of fusion genes at the protein level in leukemia patients via the flow cytometric immunobead assay
(Article)
Dekking, E. Velden, V.H.J. van der Kalina, T. Kovac, M. Evans, P. Hoogeveen, P.G. Flores-Montero Orfao, A. Comans-Bitter, W.M. Staal, F.J.T. Dongen, J.J.M. van Böttcher, S. Brüggemann, M. Sonneveld, E. Koning-Goedheer, A. Boeckx, N. Lucio, P. Sedek, L. Szczepański, T. |
2010-09-01
|
|
IKZF1 deletions predict relapse in uniformly treated pediatric precursor B-ALL
(Article)
Kuiper, R. Waanders, E. Geurts van Kessel, A.H.M. Hoogerbrugge, P.M. Velden, V.H.J. van der Reijmersdal, S.V. van Venkatachalam, R. Scheijen, B. Sonneveld, E. Dongen, J.J.M. van Veerman, A.J.P. Leeuwen, F.N. van |
2010-07-01
|
|
Cell-type-specific consequences of nucleotide excision repair deficiencies: Embryonic stem cells versus fibroblasts
(Article)
Waard, H. de Sonneveld, E. Wit, J. de Esveldt-van Lange, R. Hoeijmakers, J.H.J. Vrieling, H. Horst, G.T.J. van der |
2008-10-01
|
|
Biotransformation of brominated flame retardants into potentially endocrine-disrupting metabolites, with special attention to 2,2′,4, 4′-tetrabromodiphenyl ether (BDE-47)
(Article)
Hamers, T. Kamstra, J.H. Sonneveld, E. Murk, A.J. Visser, T.J. Velzen, M.J.M. van Brouwer, A. Bergman, A. |
2008-02-01
|
